Most of these studies have a combined predefined endpoint of the classical MACE-3 (major adverse cardiovascular endpoint) consisting of cardiovascular death, non-fatal myocardial infarct and non-fatal stroke
The two studies are being presented this week at the joint conference held by the Society for Cardiovascular Angiography & Interventions (SCAI) 2026 Scientific Sessions & Canadian Association of Interventional Cardiology (CAIC)
Antidepressants, stimulants, or dopamine agonists may provide temporary improvement in motivation, but lasting recovery typically requires behavioral and environmental changes
Glucagon in type 2 diabetes can be less effective, as it is an insulin secretagogue itself
Archived from the original (PDF) on July 9, 2009
Originally developed and FDA-approved under the brand name Egrifta, Tesamorelin was intended to reduce visceral fat accumulation in HIV-positive patients with lipodystrophy